Giles K, et al. Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM. ECTRIMS 2018, P595.
Dinutuximab β plus lage dosis IL-2 na haplo-SCT bij gerecidiveerd neuroblastoom
mei 2023 | Neuro-oncologie, Stamceltransplantatie